Keyphrases
Lung Transplantation
64%
Randomized Placebo-controlled Trial
56%
Complement Activation
56%
Antimicrobial Activity
56%
Airway Surface Liquid
56%
COVID-19
38%
Vitamin D3
38%
Airway
36%
Bronchiolitis Obliterans Syndrome
33%
Alveolar Macrophages
32%
Double-blind Trial
30%
CCR2
28%
Neutrophils
28%
Local Complementation
28%
Nanoparticle Targeting
28%
Early Indicators
28%
Monocytes
28%
Human Airways
28%
Club Cells
28%
Severe Disease
28%
Obliterative Bronchiolitis
28%
Circulating Mitochondrial DNA
28%
SARS-CoV-2 Infection
28%
Lung Ischemia-reperfusion Injury
28%
Distinctive Features
28%
Macrophage Response
28%
Glycolysis
28%
Primary Graft Dysfunction
28%
Ly6G
20%
2-Deoxy-d-glucose (2-DG)
20%
Vitamin D Status
17%
Extracorporeal Photophoresis
16%
Mitochondrial DNA
14%
LL-37
14%
Intensive Care Unit Admission
12%
Ischemia-reperfusion Injury
12%
Pulmonary Ischemia-reperfusion Injury
12%
Gene Expression
10%
Cathelicidin
10%
Antimicrobial Peptides
9%
Renal Replacement Therapy
9%
COVID-19 Outcomes
9%
Intubation
9%
Bronchoalveolar Lavage
9%
School of Medicine
9%
Area under the Curve
9%
University of Washington
8%
25(OH)D3
7%
Airway Epithelium
7%
Hypercoagulability
7%
Medicine and Dentistry
Lung Transplantation
70%
Bronchiolitis Obliterans
56%
Complement Activation
56%
COVID-19
53%
Reperfusion Injury
32%
Alveolar Macrophage
31%
Lung
31%
Antimicrobial Activity
28%
Infection
28%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Placebo
28%
Colecalciferol
28%
Macrophage Response
28%
Primary Graft Dysfunction
28%
Mitochondrial DNA
28%
Antimicrobial Agent
28%
Nanoparticle
28%
Diseases
28%
Neutrophil
28%
Extracorporeal
16%
Deoxyglucose
15%
Cathelicidin
12%
Intensive Care Unit
12%
Gene Expression
10%
Supplementation
10%
Cytotoxic T-Cell
9%
Medicine
9%
Lung Lavage
9%
Bioavailability
8%
Endothelium Injury
7%
Hypercoagulability
7%
Artificial Respiration
7%
Hypertensive Factor
5%
Renal Replacement Therapy
5%
Intubation
5%
Allograft
5%
Polypeptide Antibiotic Agent
5%
Cigarette Smoke
5%
Calcifediol
5%
Immunology and Microbiology
Lung Transplantation
100%
Bronchiolitis
56%
Airway
43%
Reperfusion
37%
Alveolar Macrophage
31%
Neutrophil
28%
Macrophage Response
28%
CCR2
28%
Antimicrobial Activity
28%
Complement Activation
28%
Antimicrobial Agent
28%
Lymphocytotoxicity
28%
Antibody Mediated Rejection
28%
Pseudomonas aeruginosa
28%
Chemokine Receptor
14%
Cytotoxic T-Cell
9%
Vitamin Blood Level
9%
Lectin Pathway
9%
Blood Plasma
9%
Allograft
7%
Exotoxin
7%
T Cell
7%
T-Helper Cell
7%
B Cell
7%
Programmed Cell Death
7%
Type Three Secretion System
7%
Neutralizing Antibody
6%
Antimicrobial Peptides
6%